With increasing industrialization, life sciences and health care companies are adopting emerging technologies to develop ‘smart health care’ and improve the overall patient experience. These increased capabilities, while leading to growth, are also leading to constant evolution of regulatory policies, and other uncertainties in the marketplace. The 2018 outlooks explore factors that are likely to shape the life sciences and health care industry in the coming year and beyond.
Life sciences companies are embracing emerging technologies to transform the entire value chain. Additionally, they are leveraging new partnerships and building new operating models to grow their business. With growth, come a few uncertainties, arising from pricing pressures, geopolitical boundaries, and policy changes. This 2018 outlook reviews the current state of the global life sciences economy and studies the trends impacting life sciences companies. It also outlines strategies that companies need to adopt to thrive in this evolving marketplace. The 2019 Global life sciences outlook will be published shortly.
With financial sustainability, care delivery, patient centricity, digital transformation, and regulatory compliance at the top of the agenda, health care sector leaders need to collaborate with all stakeholders—both within the health care ecosystem and those in converging industries—as they look to shape the future of health care and establish a sustainable smart health community.
Gain insight into key regulations that life sciences companies and health care organizations should be monitoring and addressing in 2018.